Cefprozil – Oral products
Exceptions to the recognized standard of CLSI M100
| Minimum Inhibitory Concentrations (mcg/mL) | Disk Diffusion (zone diameter in mm) | |||||
|---|---|---|---|---|---|---|
| Pathogen | S | I | R | S | I | R |
| Streptococcus pneumoniae | ≤0.5 | - | ≥1 | - | - | - |
S = Susceptible; I = Intermediate; R = Resistant
Susceptibility interpretive criteria for microorganisms are based on a dosing regimen of 500 mg q12h (adults) or 15 mg/kg q12h (pediatrics)
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Haemophilus influenzae and parainfluenzae
Enterobacteriaceae